Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-05-10
2005-05-10
Ketter, James (Department: 1636)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S300000, C435S007100, C435S007200
Reexamination Certificate
active
06891021
ABSTRACT:
We have developed a general procedure for the regulated (inducible) dimerization or oligomerization of intracellular proteins and disclose methods and materials for using that procedure to regulatably initiate cell-specific apoptosis (programmed cell death) in genetically engineered cells
REFERENCES:
patent: 5171671 (1992-12-01), Evans et al.
patent: 5834266 (1998-11-01), Crabtree et al.
patent: 6054436 (2000-04-01), Crabtree et al.
patent: 0 594 847 (1994-05-01), None
patent: WO 9201052 (1992-01-01), None
patent: WO 9323550 (1993-11-01), None
patent: WO 9325533 (1993-12-01), None
Alberg, D.G and Schreiber, S.L. Structure-Based Design of a Cyclophilin-Calcineurin Bridging Ligand.Science262, 248-250 (1993).
Albers, M.W. et al. Substrate Specificity for the Human Rotamase FKBP: A View of FK506 and Rapamycin as Leucine (twisted amide)-Proline Mimics.J. Org. Chem. 55, 4984-4986 (1990).
Albers, M.W. et al. Relationship of FKBP to PDCI-1.Nature351, 527 (1991).
Albers, M.W. et al. FKBP, Thought to be Identical to PKCI-2, Does Not Inhibit Protein Kinase C.BioMed. Chem. Lett. 1, 205-210 (1991).
Albers, M.W. et al. An FKBP-Rapamycin Sensitive, Cyclin-Dependent Kinase Activity That Correlates with the FKBP Rapamycin-Induced G1 Arrest Point in MG-63 Cells.Annals of N. Y. Acad. Sci. 696, 54-62 (1993).
Andrus, M.B. and Schreiber, S.L. Structure-Based Design of an Acyclic Ligand That Bridges FKBP12 and Calcineurin.J. Am. Chem. Soc. 115, 10420-10421 (1993).
Ben-Levy, R. et al. A oncogenic point mutation confers High Affinity Ligand Binding to the neu Receptor.J. Biol. Chem. 267, 17304-17313 (1992).
Bergsma, D.J. et al. The Cyclophilin Multigene Family of Peptidyl-Prolyl Isomerases.J. Biol. Chem. 266, 23204-23214 (1991).
Bernard, O. et al. High-affinity Interleukin-2 Binding by an Oncogenic Hybrid Interleukin-2 Epidermal Growth Factor Receptor Molecule.PNAS84, 2125-2129 (1987).
Bierer, B.E. et al. Mechanisms of Immunosuppression by FK506: Preservation of T Cell Transmembrane Signal Transduction.Transplantation49, 1168-1202 (1990).
Bierer, B.E. et al. Probing Immunosuppressant Action with a Nonnatural Immunosuppressive Ligand.Science250, 556-559 (Oct. 26 1990).
Bierer, B.E. et al, Two Distinct Signal Transmission Pathways in T Lymphocytes are Inhibited by Complexes Formed Between an Immunophilin and Either FK506 or Rapamycin.PNAS87, 9231-9235 (Dec. 1990).
Bierer, B.E. et al, The Effect of the Immunosuppressant FK506 on Alternate Pathways of T Cell Activation.Eur. J. Immunol. 21, 439-445 (1991).
Bonnerot, C. et al. Role of associated γ-chain in Tyrosine Kinase Activation via Murine FcRIII.EMBO J. 11, 2747-2757 (1992).
Bram, R.J. et al. Identification of the Immunophilins Capable of Mediating Inhibition of Signal Transduction by Cyclosporin A and FK506: Roles of Calcineurin Binding and Cellular Location.Mol. Cell. Biol. 13, 4760-4769 (Aug. 1993).
Byrn, R.A. et al. Biological Properties of a CD4 Immunoadhesin.Nature344, 667-670 (Apr. 12 1990).
Cantley, L.C. et al. Oncogenes and signal transduction.Cell64, 281-302 (Jan. 25 1991).
Chan, A.C. et al. The ζ Chain is associated with a Tyrosine Kinase and upon T-Cell Antigen Receptor Stimulation Associates with ZAP-70, a 70-kDa Tyrosine Phosphoprotein.PNAS88, 9166-9170 (Oct. 1991).
Chung, J. et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.Cell69, 1227-1235 (Jun. 26 1992).
Clark, M.R. et al. The B Cell Antigen Receptor Complex: Association of Ig-α and Ig-β With Distinct Cytoplasmic Effectors,Science258, 123-126 (Oct. 2 1992).
Clipstone, N.A. et al. Calcineurin: Molecular analysis of its interaction with drug-immunophilin complexes and its role in the regulation of NF-AT.J. Cell. Biochem. Suppl. 0 (18B) 274, Abstract #I140 (1994).
Crabtree, G. R. IL-2 receptor in the pathogenesis of human lymphoma. Abstract of NIH Grant 5R01CA039612-03 (1987).
Crabtree, G. R. Pathways of T lymphocyte activation. Abstract of NIH Grant 2R01CA039612-07 (1991).
DiLella, A.G. et al. Chromosomal Band Assignments of the Genes Encoding Human FKBP12 and FKBP13.Biochem. Biophys. Res. Commun. 189, 819-823 (Dec. 15 1992).
Donald, D.K. et al. C10 N-Acyl Modified FK-506: A Possible Hybrid Analogue of the Transition State of Petidyl-Prolyl Cis-Trans Isomerization.Tetrahedron Letters31, 1375-1378 (1991).
Durand, D.B et al. Characterization of Antigen Receptor Response Elements within the Interleukin-2 Enhancer.Mol. Cell. Biol. 8, 1715-1724 (Apr. 1988).
Eberle, M.K. and Nuninger, F. Synthesis of the Main Metabolite (OL-17) of Cyclosporin A.J. Org. Chem. 57, 2689-2691 (1992).
Edaiji, R. et al. High-Level Expression of Recombinant Human FK-Binding Protein from a Fusion Precursor.J. Prot. Chem. 11, 213-223 (1992).
Eiseman, E. and Bolen, J.B. Signal Transduction by the Cytoplasmic Domains of FcεRI-y and TCROJ-y in Rat Basophilic Leukemia Cells.J. Biol. Chem. 267, 21027-21032 (Oct. 15 1992).
Emmel, E.A. et al. Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T-Cell Activation.Science246, 1617-1620 (Dec. 22 1989).
Engel, I. et al. High-Efficiency Expression and Solubization of Functional T-Cell antigen Receptor Heterodimers.Science256, 1318-1321 (May 29 1992).
Evans, D.A. et al. Mechanistic Study of the rhodium(I)- and Iridium(I)- Catalyzed Hydroboration Reactions: Scope and Synthetic Applications.J. Am. Chem. Soc. 114, 6671-6679 (1992).
Evans et al. Mechanistic study of the rhodium(I)-catalyzed hydroboration reaction. J. Am. Chem. Soc. 114, 6679-6685 (1992).
Fields, S. & Song, O-k., A Novel Genetic System to Detect Protein-Protein Interactions.Nature340, 245-246 (Jul. 20 1989).
Fischer, G. et al. Mip protein ofLegionella pneumophilaexhibits peptidyl-prolyl-cis/trans isomerase (Pplase) activity.Mol. Microbiol. 6, 1375-1383 (1992).
Fisher, M.J. et al. On the Remarkable Propensity for Carbon-Carbon Bond Cleavage Reactions in the C8-C10 Region of FK-506.J. Org. Chem. 56, 2900-2907 (1991).
Flanagan, W.M. et al. Nuclear Association of a T-Cell Transcription Factor Blocked by a Tyrosine Factor Blocked by FK-506 and Cyclosporin A.Nature352, 803-807 (Aug. 29 1991).
Flanagan, W.M. et al. Intracellular signal transmission: a novel role for the prolyl isomerases.J. Cell. Biochem. Suppl. 0 (16 Part A) 61, Abstract #B005 (1992).
Flanagan, W.M. et al. Nuclear association of a transcription factor essential for T cell activation by cyclosporin A and FK506.J. Cell. Biochem. Suppl. 0 (16 Part B), 237, Abstract #H514 (1992).
Francavilla, A. et al. Inhibition of Liver, Kidney, and Intestine Regeneration by Rapamycin.Transplantation53, 496-498 (1992).
Fretz, H. et al. Rapamycin and FK506 Binding Proteins (Immunophilins).J. Am. Chem. Soc. 113, 1409-1411 (1991).
Friedman, J. & Weissman, I. Two Cytoplasmic Candidates for Immunophilin Action are Revealed by Affinity for a New Cyclophilin: One in the Presence and One in the Presence and One in the Absence of CsA.Cell66, 799-806 (Aug. 23 1991).
Fuh, G. et al. Rational design of potent antagonists to the human growth hormone receptorScience256, 1677-1680 (Jun. 19 1992).
Galat, A. et al. A Rapamycin-Selective 25 kDa Immunophilin.Biochemistry31, 2427-2434 (1992).
Ghosh, A.K. et al. N,N'-Disuccinimidyl Carbonate: A Useful Reagent for Alkoxycarbonylation of Amines.Tetrahedron Letters33, 2781-2784 (1992).
Gottschalk, W.K. et al. The Carboxy Terminal 100 Amino Acid Portion of the Insulin Receptor is Important for Insulin Signaling to Pyruvate Dehydrogenase.Biochem. Biophys. Res Comm. 189, 906-911 (Dec. 15 1992).
Haendler, B. et al. Complementary DNA for human T-cell cyclophilin.EMBO J. 6, 947-950 (1987).
Haendler, B. et al. Yeast cyclophilin: isolation and characterization of the protein, cDNA and gene.Gene83, 39-46 (1989).
Harding, M.W. et al. A Receptor for the Immunosuppressant FK506 is a cis-trans Peptidyl-Prolyl Isomerase.Nature341, 758-760 (1989).
Herbst, R. et al. Substrate Phosphorylation Specificity of the Human c-kit Receptor Tyrosine Kinase.J. Biol. Chem. 266, 19908-19916 (1991).
Howard, F.D. et al. The CD3ζCytoplasmic Doma
Belshaw Peter
Crabtree Gerald R.
Schreiber Stuart L.
Spencer David M.
Wandless Thomas J.
Board of Trustees of the Leland Stanford Junior University
Ketter James
Lambertson David A.
President and Fellows of Harvard College
Ropes & Gray LLP
LandOfFree
Regulated apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulated apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulated apoptosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3451167